In a country where monsoon seasons have long brought not only rain but the quiet dread of dengue fever, India has taken a meaningful step forward: its drug regulator has approved Qdenga, the nation's first vaccine against all four strains of the dengue virus, for individuals aged 4 to 60. The approval, grounded in trials spanning multiple countries and backed by WHO prequalification, arrives as thousands of Indians are hospitalised each year by a disease that has resisted simple solutions. Yet this milestone is offered not as a cure but as one more layer of protection in a long and ongoing eff
India Approves First Dengue Vaccine Qdenga for Ages 4-60
Dengue causes thousands of hospitalizations annually in India, particularly during monsoon seasons, with severe cases including dengue hemorrhagic fever potentially proving fatal.